Porphyria pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Porphyria}}
{{Porphyria}}
{{CMG}}; {{AE}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{PleaseHelp}}
 
{{CMG}}


==Overview==
==Overview==


==Pathophysiology==
==Pathophysiology==
Line 21: Line 19:


''[[Variegate porphyria]]'' (also ''porphyria variegata'' or ''mixed porphyria''), which results from a partial deficiency in [[PROTO oxidase]], manifests itself with skin lesions similar to those of porphyria cutanea tarda combined with acute neurologic attacks. All other porphyrias are either skin- or nerve-predominant.
''[[Variegate porphyria]]'' (also ''porphyria variegata'' or ''mixed porphyria''), which results from a partial deficiency in [[PROTO oxidase]], manifests itself with skin lesions similar to those of porphyria cutanea tarda combined with acute neurologic attacks. All other porphyrias are either skin- or nerve-predominant.
===Genetics===
===Genetics===
Evaluation of family members is necessary to identify latent porphyria.  All acute porphyrias are [[autosomal dominant]] except for ALA-D which is [[autosomal recessive]].
Evaluation of family members is necessary to identify latent porphyria.  All acute porphyrias are [[autosomal dominant]] except for ALA-D which is [[autosomal recessive]].
Line 27: Line 24:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Dermatology]]
[[Category:Gastroenterology]]
[[Category:Hematology]]
[[Category:Endocrinology]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 13:30, 22 July 2016

Porphyria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Porphyria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Porphyria pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Porphyria pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Porphyria pathophysiology

CDC on Porphyria pathophysiology

Porphyria pathophysiology in the news

Blogs on Porphyria pathophysiology

Directions to Hospitals Treating Porphyria

Risk calculators and risk factors for Porphyria pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Pathophysiology

In humans, porphyrins are the main precursors of heme, an essential constituent of hemoglobin, myoglobin, catalase, peroxidase, respiratory and P450 liver cytochromes.

Heme synthesis—note that some reactions occur in the cytoplasm and some in the mitochondrion (yellow)

Deficiency in the enzymes of the porphyrin pathway leads to insufficient production of heme. Heme function plays a central role in cellular metabolism. This is not the main problem in the porphyrias; most heme synthesis enzymes—even dysfunctional enzymes—have enough residual activity to assist in heme biosynthesis. The principal problem in these deficiencies is the accumulation of porphyrins, the heme precursors, which are toxic to tissue in high concentrations. The chemical properties of these intermediates determine the location of accumulation, whether they induce photosensitivity, and whether the intermediate is excreted (in the urine or feces).

There are eight enzymes in the heme biosynthetic pathway, four of which—the first one and the last three—are in the mitochondria, while the other four are in the cytosol. Defects in any of these can lead to some form of porphyria.

The hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain and an acute polyneuropathy), while the erythropoietic forms present with skin problems, usually a light-sensitive blistering rash and increased hair growth.

Variegate porphyria (also porphyria variegata or mixed porphyria), which results from a partial deficiency in PROTO oxidase, manifests itself with skin lesions similar to those of porphyria cutanea tarda combined with acute neurologic attacks. All other porphyrias are either skin- or nerve-predominant.

Genetics

Evaluation of family members is necessary to identify latent porphyria. All acute porphyrias are autosomal dominant except for ALA-D which is autosomal recessive.

References

Template:WH Template:WS